Biological Therapy in Treating Women With Metastatic Breast Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop
cancer cells from growing. Combining different types of biological therapies may kill more
tumor cells.
PURPOSE: Phase I/II trial to study the effectiveness of T cells and interleukin-2 combined
with peripheral stem cell transplantation or bone marrow transplantation in treating women
who have stage IIIB or metastatic breast cancer.